Review article: Barrett's oesophagus and carcinoma in Japan

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 20, Issue 8, 2004, Pages 50-54

  Hongo, M ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ASIA; BARRETT ESOPHAGUS; CANCER EPIDEMIOLOGY; CONFERENCE PAPER; DISEASE ASSOCIATION; ELDERLY CARE; ESOPHAGUS CARCINOMA; ESOPHAGUS DISEASE; FEMALE; GASTROESOPHAGEAL REFLUX; GENDER; GEOGRAPHIC DISTRIBUTION; HELICOBACTER PYLORI; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 10644297267     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.02230.x     Document Type: Conference Paper

References (31)

1. Spechler S, Goyal R. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterol 1996; 110: 614-21.
2. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31.
3. Pera M, Cameron A, Trastek V, et al. Increasing evidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104: 510-3.
4. Prach A, MacDonald T, Hopwood D, Johnston D. Increasing incidence of Barrett's oesophagus: education, enthusiasm or epidemiology. Lancet 1997; 350: 933.
5. Falk G, Richter J. Reflux disease and Barrett's esophagus. Endoscopy 1998; 30: 61-72.
6. Blot W, Devesa S, Kneller R, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. J Am Med Assoc 1991; 265: 1287-9.
7. Devesa S, Blot W, Fraumeni J. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1988; 83: 2049-53.
8. Powell J, McConkey C. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 1990; 62: 440-3.
9. Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000; 29: 645-54.
10. Sharma P, Morales TG, Sampliner RE. Short segment Barrett's esophagus - The need for standardization of the definition and endoscopic criteria. Am J Gastroenterol 1998; 93: 1033-6.
11. Shoji T, Hongo M, Fukudo S, et al. Increasing incidence of Barrett's esophagus and Barrett's carcinoma in Japan. Gastroenterology 1999; 116: A312 (Abstract).
12. Spechler SJ. Barrett's esophagus. Gastroenterologist 1994; 2: 273-84.
13. Sekiguchi T. Report of a survey of Barrett's esophagus (Japanese). Clinica 1992; 19: 397-9.
14. Nishio T, Makuuchi H, Nizutani G, et al. Barrett's esophagus and Barrett's epithelium in endoscopic screening (Japanese). Clinica 1996; 23 (Suppl.): 14-9.
15. Hoshihara Y, Kogure T. Endoscopic diagnosis of Barrett's epithelium (Japanese). Endoscopia Digestiv (Shoukaki Naishikyou) 1997; 9: 897-901.
16. Kumagai Y, Suyama T, Mukai M, et al. Prevalence and pathogenesis of Barrett's epithelium (Japanese). Prog Digest Endosc 1985; 27: 80-3.
17. Makuuchi H. Barrett's esophageal cancer. Gan Kagaku Ryoho 2002; 29: 161-8. [in Japanese].
18. Azuma N, Endo T, Arimura Y, et al. Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan. J Gastroenterol 2000; 35: 583-92.
19. Katzka D, Castell D. Successful elimination of reflux symptoms does not ensure adequate control of acid reflux in Barrett's esophagus. Am J Gastroenterol 1994; 89: 989-91.
20. Ter R, Catell D. Gastroesophageal reflux disease in patients with columnar-lined esophagus. Gastroenterol Clin North Am 1997; 26: 549-63.
21. Winters C, Spurling T, Chobanian S, et al. Barrett's esophagus: a prevalent, occult complication of gastroesophageal reflux disease. Gastroenterol 1987; 92: 118-24.
22. Vaezi M, Richetr J. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996; 111: 1192-9.
23. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997; 26: 487-94.
24. Armstrong D, Bennett J, Blum A, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111: 85-92.
25. Ollyo J, Monier P, Savary M. Contribution of endoscopy to gastroesophageal reflux disease. Scand J Gastroenterol 1984; 106: 26.
26. El-Searg H, Sonnenberg A, Jamal M, et al. Characteristics in intestinal metaplasia in the gastric cardia. Am J Gastroenterol 1999; 94: 622-7.
27. Wu J, Sung J, Ng E, et al. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: a study from the East. Am J Gastroenterol 1999; 94: 1790-4.
28. O'Connor HJ. Helicobacter pylori and gastroesophageal reflux disease - clinical implications and management. Aliment Pharm Ther 1999; 13: 117-27.
29. Hongo M. How does Helicobacter pylori infection affect the pathophysiology of reflux esophagitis? J Gastroenterol 1999; 34: 649-50.
30. Ohara S, Sekine H, Iijima K, et al. Gastric mucosal atrophy and Helicobacter pylori infection in elder patients with reflux oesophagitis (Japanese). Jpn J Gastroenterol 1996; 93: 235-9.
31. Drewitz D, Sampliner R, Garewal H. The incidence of adenocarcinoma in Barrett's esophagus, a prospective study of 170 patients followed 4.8 Years. Am J Gastroenterol 1997; 92: 212-5.